Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
White matter microstructural abnormalities of the cingulum bundle in youths with 22q11.2 deletion syndrome: Associations with medication, neuropsychological function, and prodromal symptoms of psychosis.
[22q11.2 deletion syndrome]
The
22
q
11
.
2
deletion
syndrome
(
22
q
11
.
2
DS
)
is
regarded
as
an
etiologically
homogenous
model
for
understanding
neuroanatomic
disruptions
associated
with
a
high
risk
for
schizophrenia
.
This
study
utilized
diffusion
tensor
imaging
(
DTI
)
to
analyze
white
matter
microstructure
in
individuals
with
22
q
11
.
2
DS
.
We
focused
on
the
cingulum
bundle
(
CB
)
,
previously
shown
to
be
disrupted
in
patients
with
schizophrenia
and
associated
with
symptoms
of
psychosis
.
White
matter
microstructure
was
assessed
in
the
anterior
,
superior
,
and
posterior
CB
using
the
tractography
algorithm
in
DTIStudio
.
Neuropsychological
function
,
presence
of
prodromal
symptoms
of
psychosis
,
and
medication
history
were
assessed
in
all
participants
.
Relative
to
controls
,
young
adults
with
22
q
11
.
2
DS
showed
alterations
in
most
DTI
metrics
of
the
CB
.
Alterations
were
associated
with
positive
prodromal
symptoms
of
psychosis
.
However
,
when
individuals
with
22
q
11
.
2
DS
were
divided
by
usage
of
antipsychotics
/
mood
stabilizers
,
the
medicated
and
non-medicated
groups
differed
significantly
in
axial
diffusivity
of
the
anterior
CB
and
in
fractional
anisotropy
of
the
superior
CB
.
DTI
metrics
did
not
differ
between
the
medicated
group
and
the
control
group
.
Results
suggest
that
the
microstructure
of
the
CB
is
altered
in
individuals
with
22
q
11
.
2
DS
,
and
that
those
alterations
may
underlie
positive
prodromal
symptoms
of
psychosis
.
Our
findings
further
provide
preliminary
evidence
that
antipsychotic
/
mood
stabilizer
usage
may
have
a
reparative
effect
on
white
matter
microstructure
in
prodromal
22
q
11
.
2
DS
,
independent
of
the
potential
effects
of
psychosis
.
Future
studies
of
white
matter
pathology
in
individuals
with
22
q
11
.
2
DS
should
test
for
potential
effects
of
medication
on
white
matter
microstructure
.
Diseases
Validation
Diseases presenting
"white matter microstructure in prodromal"
symptom
22q11.2 deletion syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom